Consumer & Travel Stock News

Tuesday, September 08, 2026

Other News

DFTX Receives FDA Breakthrough Therapy Designation for Depression Drug DT120 ODT Coca-Cola invests R17.6bn in South Africa, raising annual profit outlook Bayer launches first of 10 blockbusters, targeting €500 million peak sales each Novo Nordisk Halts Heart Drug Trials, Shares Slide on Low Success Odds BofA Securities Raises AbbVie Price Target Following Apogee Deal Sellas Life Sciences faces investigation, stock sinks 13% on delayed trial results Frazier Life Sciences Takes 7.4% Stake in Achieve, Backing Nicotine Treatment Frazier Life Sciences Buys $24M Kailera Stake, Targeting GLP-1 Obesity Market Connect Biopharma Nears Phase 2 Rademikibart Data for Asthma and COPD Relay Therapeutics Lands $19 Million Frazier Stake Amid Insider Selling Celsius Holdings Sued Over Alani Nu Safety, Alleging Risks to Teens Roivant Surges 21% on Blockbuster Lung Drug Data — But Can a Phase 2 Win Sustain a $7 Billion Bet? Beam Therapeutics Surges 9% on Fresh Gene-Editing Data — But Can a One-Time Cure Justify a $3 Billion Bet? Navan, Inc. Q2 2027 Earnings Preview: What Analysts Expect on September 09, 2026 Palatin Technologies, Inc. Q2 2026 Earnings Preview: What Analysts Expect on September 09, 2026 Alzamend Neuro Inc Q3 2026 Earnings Preview: What Analysts Expect on September 09, 2026 Anixa Biosciences Inc Q3 2026 Earnings Preview: What Analysts Expect on September 09, 2026 China to Inject Over $50 Billion Into Financial System Ind-Swift's Warrant Price Set at Half Its Market Value — Is the Discount a Dilution Risk or a Confidence Signal?